Literature DB >> 7093245

Inhibition of anion transport in the red blood cell by anionic amphiphilic compounds. II. Chemical properties of the flufenamate-binding site on the band 3 protein.

J L Cousin, R Motais.   

Abstract

Flufenamate is a powerful inhibitor of anion exchange in red blood cells. It binds to the band 3 protein involved in the transport as discussed in the preceding paper (Cousin, J.-L. and Motais, R. (1982) Biochim. Biophys. Acta 687, 147-155). The present study is concerned with the chemical properties of the inhibitory binding site. Structure-activity studies were performed with two sets of compounds derivated from anthranilate (considered as the basic structure of flufenamate). The molar concentrations required to produce 50% inhibition (I50) varied over more than a 10(4) range. The inhibitory activity was quantitatively correlated with the hydrophobic character of the molecules and the electron-withdrawing capacity of the substituents. Comparison between the inhibitory potency of flufenamate analogs made a definition of the contribution of each part of the molecule in the binding to the receptor possible. The results suggest that anionic inhibitors bind to a site which presents a positively charged groups at the water-protein interface whereas the hydrophobic part of the molecule is inserted into an hydrophobic and electron-donor region of the protein. The specificity of amphiphilic compounds towards anion transport is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093245     DOI: 10.1016/0005-2736(82)90541-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Effects of arylaminobenzoate-type chloride channel blockers on equivalent short-circuit current in rabbit colon.

Authors:  R Greger; R B Nitschke; E Lohrmann; I Burhoff; M Hropot; H C Englert; H J Lang
Journal:  Pflugers Arch       Date:  1991-09       Impact factor: 3.657

2.  Calcium-activated chloride current in rat vascular smooth muscle cells in short-term primary culture.

Authors:  P Pacaud; G Loirand; J L Lavie; C Mironneau; J Mironneau
Journal:  Pflugers Arch       Date:  1989-04       Impact factor: 3.657

3.  Triflocin, a novel inhibitor for the Na-HCO3 symport in the proximal tubule.

Authors:  F Belachgar; P Hulin; T Anagnostopoulos; G Planelles
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

Review 4.  Oligomeric structure and the anion transport function of human erythrocyte band 3 protein.

Authors:  M L Jennings
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

5.  Control of cell volume and ion transport by beta-adrenergic catecholamines in erythrocytes of rainbow trout, Salmo gairdneri.

Authors:  F Borgese; F Garcia-Romeu; R Motais
Journal:  J Physiol       Date:  1987-01       Impact factor: 5.182

Review 6.  How do loop diuretics act?

Authors:  M Wittner; A Di Stefano; P Wangemann; R Greger
Journal:  Drugs       Date:  1991       Impact factor: 9.546

7.  Role of Lys 558 and Lys 869 in substrate and inhibitor binding to the murine band 3 protein: a study of the effects of site-directed mutagenesis of the band 3 protein expressed in the oocytes of Xenopus laevis.

Authors:  P G Wood; H Müller; M Sovak; H Passow
Journal:  J Membr Biol       Date:  1992-04       Impact factor: 1.843

8.  Different types of blockers of the intermediate-conductance outwardly rectifying chloride channel in epithelia.

Authors:  M Tilmann; K Kunzelmann; U Fröbe; I Cabantchik; H J Lang; H C Englert; R Greger
Journal:  Pflugers Arch       Date:  1991-07       Impact factor: 3.657

9.  Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein.

Authors:  R C Hogg; Q Wang; W A Large
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

10.  Hormone-induced co-transport with specific pharmacological properties in erythrocytes of rainbow trout, Salmo gairdneri.

Authors:  A Baroin; F Garcia-Romeu; T Lamarre; R Motais
Journal:  J Physiol       Date:  1984-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.